Back to search
Platinum-resistant Recurrent Ovarian Cancer (PROC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Platinum-resistant Recurrent Ovarian Cancer (PROC) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Platinum-resistant Recurrent Ovarian Cancer (PROC) trials you may qualify forA Phase 1, single-arm, single-center, open-label, prospective, dose-escalation, and cohort expansion study to assess the safety, tolerability, pharmacokinetic (…
As one of the gynecological malignancies with the highest incidence and mortality rates worldwide, ovarian cancer treatment faces the significant challenge of p…